Rapid real‐world data analysis of patients with cancer, with and without <scp>COVID</scp>‐19, across distinct health systems

RWD can be rapidly leveraged to understand urgent healthcare challenges. Patients with cancer are more vulnerable to COVID-19 effects, especially in the setting of active cancer and comorbidities, with additional risk observed in NHB patients and those living in zip codes with median household income <$30 000.